Our Practice

The Paul, Weiss Patent Litigation practice is defined by our singular passion for science and technology. We are not just lawyers who understand science—we are scientists who have chosen law as our vehicle for solving complex technological challenges. With deep training spanning biochemistry, molecular biology, immunology, organic and analytic chemistry, computer science, electrical engineering, mechanical engineering, physics-engineering and beyond, our lawyers understand and can translate intricate technical details into compelling legal narratives that resonate with judges, juries and arbitrators.

Patent disputes frequently involve a chessboard of challenges across jurisdictions and venues, including the U.S. District Courts, the U.S. Court of Appeals for the Federal Circuit, the U.S. International Trade Commission, the U.S. Patent Trial and Appeal Board, and arbitration bodies. Our team has collectively handled hundreds of disputes across these various forums, most often with multiple parallel proceedings at the same time.  

Disputes over patented innovations often implicate antitrust, trade secrets and other claims. We work hand in hand with our industry-leading Litigation Department to deliver integrated, proactive solutions to protect our clients’ innovations and their businesses.

EXPERIENCE

Our patent litigators have handled significant, bet-the-company matters involving innovations in the following sectors, among others:

• Biologics, including antibodies and other complex macromolecules across the therapeutic areas of eye disease, oncology, rare diseases, blood disorders, immunotherapy, as well as the methods by which biologics are created, purified and manufactured;
• Pharmaceuticals and biotechnology, including established innovative small-molecule drugs facing generic challenges and new drugs at the leading edge of development, from antipsychotics to dermatologic treatments to drugs for rare vision disorders and autoimmune diseases; instruments and assays used in spatial biology; and genetics testing;
• Medical devices, including transcatheter heart valves, inhalation technologies, hip and knee prostheses, surgical and robotic technology, blood collection devices and injection technologies;
• Communications, electronics and computing products, including telecommunications software, internet method/information storage systems, computer network management software, network security software, speech recognition and medical records software, medical imaging software, signal processing applications and methods, integrated circuit design, fabrication and interfaces, LEDs, LDs, alkaline and hearing aid batteries, CDs and DVDs, audiotape cassette technology, word processing, barcode and machine vision technology, semiconductors, flat-panel display technology and fiber optics;
• Consumer products, including smoking cessation technologies, inhalation and aerosol technologies, automotive self-driving technology, shaving products, cosmetics, hair dryers, toothbrushes, and in-mold labeling tubes; and
• Industrial technologies, including metallurgical, petroleum, polymer, and other chemical and material innovations, and gas and wind turbines.